|
Corneal Crosslinking Sites in the US
Corneal Crosslinking (CXL), a procedure first developed in Dresden, Germany in the 1990's, has the potential to stop the progression of Keratoconus. This is a treatment option under investigation for individuals with progressive keratoconus to stabilize the cornea.
Corneal Crosslinking (CXL) has been used in Europe and other countries for several years and is currently undergoing FDA clinical trials in the United States.
While data from these initial clinical trials is being collected for review by the FDA, a number of sites in the United States are offering corneal crosslinking under investigator sponsored clinical studies. These sites are using protocols approved by various Institutional Review Boards.
All the following studies are listed on the National Institute for Health (NIH) website: ClinicalTrials.gov or have IRB approval.
(An Institutional Review Board (IRB) is a committee formally designated to approve, monitor and review research involving human subjects to protect the rights and welfare of the research subjects. The Food and Drug Administration (FDA) and the Office of Protection from Research Risks (part of the National Institutes of Health) set the guidelines and regulations governing human subjects research and IRBs.)
Note: Cost for this procedure varies. Call the offices for specific information.
These sites are now open and enrolling patients.
ARIZONA (CXL) http://clinicaltrials.gov/ Identifier: NCT01189864 Jay L. Schwartz, MD Schwartz Laser Eye Center 8416 E. Shea Blvd Ste C-101 Scottsdale, AZ 85260 Contact: 480-483-3937
CALIFORNIA
(CXL) http://clinicaltrials.gov/ Identifier: NCT01081561 Principal Investigator: Yaron Rabinowitz, MD Principal Investigator: Yuri Oleynikov, M.D. PhD Eye Surgery Center of Beverly Hills Cornea Genetic Eye Institute 50 La Cienega Blvd. Ste 340 Los Angeles, CA 90048 Contact: Betty Cardenas (310) 423-9640 Contact: Martha Bucaram (310) 423-9640
(CXL) http://clinicaltrials.gov/ Identifier: NCT01081561 Principal Investigator: Ezra Maguen, M.D. American Eye Institute 8635 West 3rd Street Los Angeles, CA 90048-6150 Contact: Bernie Ruane (310) 652-1133
(CXL) http://clinicaltrials.gov/ Identifier: NCT01081561 Principal Investigator: James Salz, M.D. Laser Eye Associates 240 So. La Cienega Blvd., Suite 250 Beverly Hills, CA 90211 Contact: Donna Jones (310) 360-0609
(CXL) http://clinicaltrials.gov/ Identifier: NCT01081561 Principal Investigator: Ronald N. Gaster, MD University of California-Irvine 1 Medical Plaza Drive Irvine, CA 92617 Contact:(949) 824-8089
(CXL) http://clinicaltrials.gov/ Identifier: NCT01097447 Principal Investigator: David A. Wallace, M.D. LA Sight 11600 Wilshire Blvd. Suite 200 Los Angeles CA 90025 Contact: Karen Morascko (310) 828-2020/ (877) 828-2020
(CXL) http://clinicaltrials.gov/ Identifier: NCT01097447 Principal Investigator: Sandy Feldman, M.D. Clear View Eye & Laser Medical Center 6255 Lusk Blvd., Suite 100 San Diego, CA 92121 Contact : 858- 452-3937
COLORADO
(CXL) http://clinicaltrials.gov/ Identifier: NCT01097447 Principal Investigator: Lance Forstot, MD Corneal Consultants of Colorado 8381 Southpark Lane Littleton, CO 80120 Contact: Steven Cho (303) 730-0404
FLORIDA
(CXL) http://clinicaltrials.gov/ Identifier: NCT01024322 Principal Investigator: William Trattler, MD Center for Excellence in Eye Care 8940 N. Kendall Drive; #400E Miami, FL 33176 Contact: Melissa Earl or Jenna Piel (951) 653-5566
GEORGIA
(CXL) http://clinicaltrials.gov/ Identifier: NCT00567671 Principal Investigator: Doyle Stulting, MD Woolfson Eye Institute (previously at Emory University) 800 Mt. Vernon Hwy, Suite 120 Atlanta, GA 30328 Contact: Dr. Stulting (770) 255-3330
(CXL) http://clinicaltrials.gov Identifier: NCT01190306 Principal Investigator: R. Doyle Stulting, M.D., Ph.D Woolfson Eye Institute 800 Mt. Vernon Hwy, Suite 120 Atlanta, GA 30328 Contact: Jodi Miller 770- 255-3330
ILLINOIS
(CXL) http://clinicaltrials.gov Identifier: NCT01097447 Investigator: Parag A. Majmudar, MD Chicago Cornea Consultants, Ltd. 1585 N. Barrington Road, Suite 502 Hoffman Estates, IL 60169 Contact : Jim Nykaza (847) 882-5900
INDIANA
(CXL) http://clinicaltrials.gov/ Identifier: NCT01143389 Principal Investigator: Francis Price, MD Price Vision Group 9002 N. Meridian St. Ste.100 Indianapolis, IN 46260 Contact: Marianne Price, PhD 317-844-5530
MASSACHUSETTS
(CXL) http://clinicaltrials.gov/ Identifier: NCT00841386 Principal Investigator: Kathryn Colby, MD, PhD Co-Investigator: Roberto Pineda II, MD Massachusetts Eye and Ear Infirmary 243 Charles Street Boston, MA 02114 Contact: Cornea Research Dept: (617) 573-3313
MARYLAND
(CXL) http://clinicaltrials.gov/ Identifier: NCT01024322 Principal Investigator: Roy Rubinfeld, MD Washington Eye Center 5454 Wisconsin Ave, Suite 950 Chevy Chase, MD 20815 Contact: Roy Rubinfeld, MD (301) 654-5114
MINNESOTA
(CXL) http://clinicaltrials.gov/ Identifier: NCT01190306 Principal Investigator: David Hardten, M.D. Minnesota Eye Consultants Bloomington, Minnesota, 55431 Contact: Lindsey Fallenstein 952-567-6060 Jill Spude 952-567-6070
NEW JERSEY
(CXL) http://clinicaltrials.gov/ Identifier: NCT01112072
(CXL) http://clinicaltrials.gov/ Identifier: # NCT01152541 Principal Investigator: Peter Hersh, MD Cornea and Laser Eye Institute 300 Frank W. Burr Blvd - Suite 71 Teaneck, New Jersey 07666 Contact: Dr. Kristen Fry (201) 883-0505
NEW YORK
(CXL) http://clinicaltrials.gov/ Identifier: NCT00841386 Principal Investigator: James J Reidy, M.D. Co-Investigator: Thomas Elmer, MD Ira G. Ross Eye Institute 1176 Main Street Buffalo, NY 14209 Contact: Jeanne Stutz (716) 881-7920
(CXL) http://clinicaltrials.gov/ Identifier: NCT00841386 Principal Investigator: Michael Endl, M.D. Co-Investigator: Thomas R Elmer, M.D. Fichte, Endl, & Elmer EyeCare Creekside Center 2825 Niagara Falls Blvd., Suite 130 Amherst, NY 14228 Contact: Linda Grant (716) 564-2020
(CXL) IRB Approval #103706 Principal Investigator: Stephen Trokel, MD Columbia University / Harkness Eye Institute 635 West 165th Street New York, NY 10032 Contact: David Mun (212) 305-5922
(CXL) http://ClinicalTrials.gov Identifier: NCT01189864 Principal Investigator: Jodi Luchs, M.D. South Shore Eye Care 2185 Wantagh Ave Wantagh, NY 11793 Contact: Dr. Luchs 516-785-3900
(CXL) http://clinicaltrials.gov/ Identifier: NCT01190306 Principal Investigator: Gregory Pamel, M.D. Pamel Vision & Laser Group New York, NY 10021 Contact: D. Sawhney, O.D. 212-355-2215
(CXL) http://clinicaltrials.gov// Identifier: NCT01190306 Principal Investigator: Penny Asbel, M.D. Mt. Sinai Hospital New York, NY 10029 Contact: Peter Dentone 212-824-7644
OHIO
(CXL) http://clinicaltrials.gov/ Identifier: NCT01189864 Principal Investigator: Shamik Bafna, MD Cleveland Eye Clinic 7001 S. Edgerton Rd. Suite B Breckville, OH 44141 Contact: 440-526-1974
(CXL) http://clinicaltrials.gov/ Identifier: NCT01190306
Principal Investigator: Ron Krueger, M.D. Cleveland Clinic - Cole Eye Institute Cleveland, OH 44195 Contact: Fadiah Alkhawaldeh 216-445-3641
(CXL) http://clinicaltrials.gov/ Identifier: NCT01190306 Principal Investigator: Thomas Mauger, M.D. OSU Department of Ophthalmoloty Columbus, OH 43212 Contact: Barbara Landolfi 614-293-8760 TEXAS
(CXL) www.ClinicalTrials.gov Identifier: NCT01097447 Principal Investigator: Bradley Bowman, M.D. Cornea Associates of Texas 7150 Greenville, Ste. 600 Dallas, TX 75231 Contact: 214-692-0146
(CXL) http://clinicaltrials.gov/ Identifier: NCT01190306
Principal Investigator: Stephen Slade, M.D.
Slade & Baker Vision Center
Houston, TX 77027
Contact: Rosie Ramirez 713-626-5544
NKCF advises caution to patients who may be considering non approved clinical trials.
|